Reaching blood pressure targets in patients with chronic kidney disease is a challenge, but can be more easily achieved with greater continuity of care.

Despite recent exponential growth in research on familial hypercholesterolaemia, there remains a general lack of public and health professional awareness about the disorder.

There is room for improvement in monitoring patients with early chronic kidney disease when considering alignment with national guidelines.

Screening and management in general practice has the potential for substantial health benefits while requiring relatively modest investments from the health system.

Guidelines on assessing and managing lipid disorders are evolving as new knowledge and treatments emerge to help health professionals and patients decide the best course of disease management.

Physical inactivity is a major modifiable contributor to the global burden of cardiovascular disease morbidity and mortality.

The recent increased public experience with epidemiological concepts such as contact tracing offers new potential to improve detection and management of familial hypercholesterolaemia.

Patient health literacy is a barrier to both management of familial hypercholesterolaemia and cascade testing.

Recent consensus advice on the care of patients with familial hypercholesterolaemia (FH) supports improved care of patients with FH in the primary care setting.

Exercise is a safe and effective treatment modality to assist in the control of glucose levels and reduce complications for individuals with type 2 diabetes.